Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y000223 | IM / LL |
1605 MMR vaccine administered 1615 MOC reports redness, hives and shortness of breath. Patient is alert and oriented able to make needs known. Flushing to the face with hives, mouth breathing with drool. High pitched voice with speaking. Audible wheeze present 1617 Pediatric epi (0.15mg) administered IM right thigh. 1620 Spo2 93%, HR 134 - Dr, assessment = diminished breath sounds, requesting Albuterol and oxygen 1621 Inhaled albuterol 2 puffs with aerochamber no mask (supplied by MOC), applied O2 at 3L via face mask and given childrens zyrtec liquid 5mg. 1625 Spo2 94% - Dr. assessment = increasing air flow, request for benadryl. Dose clarification with Dr. 1627 EMT arrive on scene, report given with copy of medications and interventions 1629 Benadryl 21.25 mg administered IM left thigh, Spo2 98% 1630 Transferred to Hospital via ambulance Breath sounds and macular rash improving by exam at time of transfer and child maintaining sats on RA without difficulty.
none
Gastroesophageal reflux disease, Gastroparesis Syndrome, Pulmonary Artery Stenosis, Sensory integration disorder, Speech Delay, Urticaria
Aspirin 81 mg (daily), Zytrec 1mg/ml (10 ml), Vitamin, Symbicort 80 mcg/4.5mcg (2 puffs twice daily), Tums 200 mg (daily)
adhesive tape, chloraPrep Clear
none